Global Hyperimmune Globulins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

SKU ID : GIR- 13003900

Publishing Date : 21-Jan-2019

No. of pages : 116

PRICE
3480
6960


  • Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

    Scope of the Report:
    Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
    The worldwide market for Hyperimmune Globulins is expected to grow at a CAGR of roughly 11.6% over the next five years, will reach 140 million US$ in 2024, from 82 million US$ in 2019, according to a new study.
    This report focuses on the Hyperimmune Globulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    CSL Behring
    Grifols
    Biotest
    Kedrion
    CBPO
    Emergent (Cangene)
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    ADMA Biologics

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Rho(D) Immunoglobulins
    Others

    Market Segment by Applications, can be divided into
    Government Institutions
    Private Sector
    Other

    There are 15 Chapters to deeply display the global Hyperimmune Globulins market.
    Chapter 1, to describe Hyperimmune Globulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
    Chapter 2, to analyze the top manufacturers of Hyperimmune Globulins, with sales, revenue, and price of Hyperimmune Globulins, in 2017 and 2018;
    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
    Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyperimmune Globulins, for each region, from 2014 to 2019;
    Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
    Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
    Chapter 12, Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
    Chapter 13, 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports